Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Shilpa Medicare Management Change

Shilpa Medicare appointed Dr. Uday N. Harle as CEO of its wholly owned subsidiary, Shilpa Biologicals Private Limited. The appointment is effective from August 3, 2026.

Source

NSE filing, NSE: SHILPAMED. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Shilpa Medicare Ltd: key numbers

Share price
₹932.00
Market cap
₹18,228 Cr
Revenue (annual)
₹1,539 Cr
Net profit (annual)
₹243.3 Cr
P/E (TTM)
61.3×Sector 46.1×
Promoter holding
40.13%+0.00% QoQ
FII holding
12.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Shilpa Medicare Ltd

All →

Other management change announcements

All →